LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
Reporting ownerCIK 0001644975

Jon Congleton

25 transactions in 3 companies, from October 13, 2025 to September 30, 2026.

Transactions
253 companies
Bought · P
$0open market
Sold · S
$16.8Mopen market
Net
−$16.8Mnet selling

By company

Where this insider traded.

CompanyTickerTradesBoughtSold
Mineralys Therapeutics, Inc.MLYS22—$16.8M
IMMUNIC, INC.IMUX2——
Avalyn Pharma Inc.AVLN1——

All transactions

25 in total, newest filings first.

CompanyTickerInsiderDateCodeSharesPriceValue
Mineralys Therapeutics, Inc.MLYSJon CongletonCEOSep 30SPLAN75,000$25.46$1.9M
Mineralys Therapeutics, Inc.MLYSJon CongletonCEOJul 13SPLAN10,700$27.24$291K
IMMUNIC, INC.IMUXJon CongletonDirDERIVJul 5A25,370$0.00—?
Mineralys Therapeutics, Inc.MLYSJon CongletonCEOJun 30SPLAN17,000$26.82$456K
Mineralys Therapeutics, Inc.MLYSJon CongletonCEOJun 30SPLAN58,000$25.94$1.5M
IMMUNIC, INC.IMUXJon CongletonDirDERIVJun 29A50,740$0.00—?
Avalyn Pharma Inc.AVLNJon CongletonDirDERIVApr 29A26,978$0.00—?
Mineralys Therapeutics, Inc.MLYSJon CongletonCEOApr 13SPLAN15,730$26.83$422K
Mineralys Therapeutics, Inc.MLYSJon CongletonCEOMar 31SPLAN453$27.05$12K
Mineralys Therapeutics, Inc.MLYSJon CongletonCEOMar 31SPLAN55,183$26.54$1.5M
Mineralys Therapeutics, Inc.MLYSJon CongletonCEOMar 31SPLAN19,364$25.50$494K
Mineralys Therapeutics, Inc.MLYSJon CongletonCEODERIVFeb 19A187,900$0.00—?
Mineralys Therapeutics, Inc.MLYSJon CongletonCEOFeb 19A140,900$0.00—
Mineralys Therapeutics, Inc.MLYSJon CongletonCEOJan 12SPLAN7,117$33.15$236K
Mineralys Therapeutics, Inc.MLYSJon CongletonCEOJan 12SPLAN9,119$32.21$294K
Mineralys Therapeutics, Inc.MLYSJon CongletonCEODERIVNov 21M24,082$0.00—?
Mineralys Therapeutics, Inc.MLYSJon CongletonCEONov 21M24,082$0.54$13K
Mineralys Therapeutics, Inc.MLYSJon CongletonCEONov 11S32,850$46.89$1.5M
Mineralys Therapeutics, Inc.MLYSJon CongletonCEONov 11S112,275$45.83$5.1M
Mineralys Therapeutics, Inc.MLYSJon CongletonCEONov 11S29,207$45.20$1.3M
Mineralys Therapeutics, Inc.MLYSJon CongletonCEONov 11S4,000$43.50$174K
Mineralys Therapeutics, Inc.MLYSJon CongletonCEONov 11S8,862$42.31$375K
Mineralys Therapeutics, Inc.MLYSJon CongletonCEONov 11S12,806$41.64$533K
Mineralys Therapeutics, Inc.MLYSJon CongletonCEOOct 13SPLAN1,552$43.03$67K
Mineralys Therapeutics, Inc.MLYSJon CongletonCEOOct 13SPLAN13,548$42.63$578K